Toward a common therapeutic framework in castration-resistant prostate cancer: A model for urologic oncology and medical oncology interaction

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Background: The rapid evolution of palliative therapeutic choices in the last few years for patients with advanced castration-resistant prostate cancer (CRPC) has resulted in a dilemma currently troubling a few other epithelial malignancies: which systemic agent to choose and at what time? In addition, which specialty specifically directs the delivery of such care-Urology or Medical Oncology-has not been clearly established. Approach: Recognizing the lack of consensus, we propose a framework for Urology and Medical Oncology interactions that is founded on models that have succeeded in the past. Conclusion: This approach aims to focus the care on the patient with CRPC rather than on his physicians and promises to improve patient outcomes in this disease state.

Original languageEnglish (US)
Pages (from-to)380-382
Number of pages3
JournalUrologic Oncology: Seminars and Original Investigations
Volume32
Issue number4
DOIs
StatePublished - 2014

Keywords

  • Castration-resistant prostate cancer
  • Interactions
  • Medical urology
  • Urology

ASJC Scopus subject areas

  • Oncology
  • Urology

Fingerprint Dive into the research topics of 'Toward a common therapeutic framework in castration-resistant prostate cancer: A model for urologic oncology and medical oncology interaction'. Together they form a unique fingerprint.

  • Cite this